K-V Pharmaceutical Co. KVPHQ Company Overview Stock

New Post Public Reply Private Reply Replies (0) Message Board

Aug 31, 2013 at 11:04 PM

K-V Pharmaceutical Co. KVPHQ Company Overview

Stock Message Board http://investorshangout.com/search?q=KVPHQ&am...mp;yt1=Go!

K-V Pharmaceutical Co. KVPHQ Current Price and Quotes
0.118
Previous Close
0.108
Open
0.10

Daily Range
0.123 - 0.10
52wk Range
0.82 - 0.026

Volume
790,954
Dividend
N/A

Average Vol (3m)
1,974,085
Yield
N/A

K-V Pharmaceutical Co. KVPHQ
Company Information
2280 Schuetz Road
St. Louis, MO 63146

Website: http://www.kvph.com
Phone: 314-645-6600

K-V Pharmaceutical Co. KVPHQ
K-V Pharmaceutical Co. KVPHQ
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Mar 31, 2012 10-K
CIK 0000057055
Fiscal Year End 3/31
OTC Marketplace OTC Pink Limited
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Bankrupt
Incorporated In: DE, USA
Year of Inc. 1971
Employees Not Available
Company Officers/Contacts
Gregory Divis President, CEO
Thomas McHugh CFO
Patrick Christmas General Counsel, Secretary
Debbie Lanemann Legal Asst.
Company Directors
Not Available
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

K-V Pharmaceutical Co. KVPHQ
KVPHQ Security Details Other Company Securities
Share Structure
Market Value1 Not Available
Shares Outstanding Not Available
Float Not Available
Authorized Shares Not Available
Par Value 2.05
Shareholders
Shareholders of Record Not Available
Security Notes
Issued=12-91 Per distribution to holders of Class B Com Basis: 1 sh Class A Com for each sh Class B Com held 12-2-91
Capital Change=Capital Change=shs increased by 3 for 2 split. . Ex-date=09/08/2000. Rec date=08/28/2000. Pay date=09/07/2000.
Short Selling Data
Short Interest 2,161,472 (-38.71%)
Aug 15, 2013
Significant Failures to Deliver No
Transfer Agent(s)

K-V Pharmaceutical Co. KVPHQ Recent News

Aug 5, 2013 Ther-Rx Corporation Announces the Availability of Clindesse® (Clindamycin Phosphate) Vaginal Cream, 2% for Prescribing

K-V Pharmaceutical Co. KVPHQ Financials
Period Ending Mar 31, 2012 Mar 31, 2011 Mar 31, 2010 Mar 31, 2009
Total Revenue 23,200 27,300 9,100 113,200
Cost of Revenue 2,300 1,100 1,600 15,100
Gross Profit 20,900 26,200 7,500 98,100
Operating Expenses
Research and Development 16,100 19,100 27,100 69,800
Sales, General and Admin. 114,300 101,100 111,700 220,700
Non-Recurring Items 31,700 7,500 174,000 98,400
Other - - - -
Operating Income (141,200) (101,500) (305,300) (290,800)
Income From Continuing Operations
Add'l Income/Expense Items 92,400 (130,900) 5,800 (6,300)
Earnings Before Interest and Tax (48,800) (232,400) (299,500) (297,100)
Interest Expense 39,200 15,700 8,000 9,300
Earnings Before Tax (88,000) (248,100) (307,500) (306,400)
Income Tax 10,000 7,800 (23,900) (38,600)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (98,000) (255,900) (283,600) (267,800)
Non Recurring Events
Discontinued Operations (4,300) (15,800) - (45,800)
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (102,300) (271,700) (283,600) (313,600)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (102,300) (271,700) (283,600) (313,600)

KVPHQ K-V Pharmaceutical Co. Research DD Guide

KVPHQ K-V Pharmaceutical Co. Stock Message Board http://investorshangout.com/search?q=KVPHQ&am...mp;yt0=Go!
KVPHQ K-V Pharmaceutical Co. Stock Quote http://www.otcmarkets.com/stock/KVPHQ/quote
KVPHQ K-V Pharmaceutical Co. Stock Chart http://www.otcmarkets.com/stock/KVPHQ/chart
KVPHQ K-V Pharmaceutical Co. Company Info http://www.otcmarkets.com/stock/KVPHQ/company-info
KVPHQ K-V Pharmaceutical Co. Recent News http://www.otcmarkets.com/stock/KVPHQ/news
KVPHQ K-V Pharmaceutical Co. Financials http://www.otcmarkets.com/stock/KVPHQ/financials
KVPHQ K-V Pharmaceutical Co. Filings and Disclosure http://www.otcmarkets.com/stock/KVPHQ/filings
KVPHQ K-V Pharmaceutical Co. Short Sales http://www.otcmarkets.com/stock/KVPHQ/short-sales
KVPHQ K-V Pharmaceutical Co. Insider Disclosure http://www.otcmarkets.com/stock/KVPHQ/insider-transactions
KVPHQ K-V Pharmaceutical Co. Research Reports http://www.otcmarkets.com/stock/KVPHQ/research
KVPHQ K-V Pharmaceutical Co. Summary http://finance.yahoo.com/q?s=KVPHQ
KVPHQ K-V Pharmaceutical Co. Historical Prices http://finance.yahoo.com/q/hp?s=KVPHQ+Historical+Prices
KVPHQ K-V Pharmaceutical Co. Interactive Chart http://finance.yahoo.com/echarts?s=KVPHQ
KVPHQ K-V Pharmaceutical Co. Basic Chart http://finance.yahoo.com/q/bc?s=KVPHQ+Basic+Chart
KVPHQ K-V Pharmaceutical Co. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=KVPHQ+Basic+Tech.+Analysis
KVPHQ K-V Pharmaceutical Co. Headlines http://finance.yahoo.com/q/h?s=KVPHQ+Headlines
KVPHQ K-V Pharmaceutical Co. Press Releases http://finance.yahoo.com/q/p?s=KVPHQ+Press+Releases
KVPHQ K-V Pharmaceutical Co. Company Profile http://finance.yahoo.com/q/pr?s=KVPHQ+Profile
KVPHQ K-V Pharmaceutical Co. Key Statistics http://finance.yahoo.com/q/ks?s=KVPHQ+Key+Statistics
KVPHQ K-V Pharmaceutical Co. Industry http://finance.yahoo.com/q/in?s=KVPHQ+Industry
KVPHQ K-V Pharmaceutical Co. Major Holders http://finance.yahoo.com/q/mh?s=KVPHQ+Major+Holders
KVPHQ K-V Pharmaceutical Co. Insider Transactions http://finance.yahoo.com/q/it?s=KVPHQ+Insider+Transactions
KVPHQ K-V Pharmaceutical Co. Insider Roster http://finance.yahoo.com/q/ir?s=KVPHQ+Insider+Roster
KVPHQ K-V Pharmaceutical Co. Income Statement http://finance.yahoo.com/q/is?s=KVPHQ
KVPHQ K-V Pharmaceutical Co. Balance Sheet http://finance.yahoo.com/q/bs?s=KVPHQ
KVPHQ K-V Pharmaceutical Co. Cash Flow http://finance.yahoo.com/q/cf?s=KVPHQ+Cash+Flow&annual
KVPHQ K-V Pharmaceutical Co. Nasdaq http://www.nasdaq.com/symbol/KVPHQ
KVPHQ K-V Pharmaceutical Co. Market Watch http://www.marketwatch.com/investing/stock/KVPHQ
KVPHQ K-V Pharmaceutical Co. Bloomberg http://www.bloomberg.com/quote/KVPHQ:US
KVPHQ K-V Pharmaceutical Co. Morningstar http://quotes.morningstar.com/stock/s?t=KVPHQ
KVPHQ K-V Pharmaceutical Co. Bussinessweek http://investing.businessweek.com/research/st...cker=KVPHQ
KVPHQ K-V Pharmaceutical Co. Barchart http://www.barchart.com/quotes/stocks/KVPHQ
KVPHQ K-V Pharmaceutical Co. OTC Short Report http://otcshortreport.com/index.php?index=KVPHQ
KVPHQ K-V Pharmaceutical Co. Investopedia http://www.investopedia.com/markets/stocks/KVPHQ/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rural Hospitals Face Shaky Future; Warbird RCM Steps In

Revamping Revenue Cycle Management for Rural Healthcare In a world that's increasingly teetering on the delicate tightrope of balance sheets, Warbird Healthcare Advisors is stepping into the ring with fists up, ready to fight for rural hospitals. Introducing their latest venture, Warbird RCM Partners, they're honing in on revenue cycle management and billing services to...

When Families Should Consider Life Insurance Plans

Let’s talk about why life insurance isn’t just for those walking around with gray hair. K.D. the Insurance Queen from Centennial, Colorado, dishes out the clearest advice on when and why families ought to have it in their arsenal. A New Mindset on Life Insurance Some folks out there think life insurance is something you ponder in your twilight years. But here’s the...

Critical Questions to Ask When Buying Life Insurance

Getting Under the Hood of Life Insurance Alright, so you're thinking about life insurance. Not exactly a day at the beach, but it’s one of those crucial life things to nail down. Paula Miller, a savvy insurance pro, walks through what to consider before you just slap down a signature and hope for the best. The Basics: Policy Types and Coverage Life insurance can be as...

Centrus Energy to Discuss Q3 Earnings on Nov 5 Call

Centrus Energy Prepares for Earnings Call You ever feel that twinge in your gut right before a big disclosure? Well, that's where Centrus Energy’s about to take us as they gear up for their quarterly earnings call. On November 5th, bright and early at 8:30 a.m. Eastern Time, NYSE:LEU will be in the spotlight, laying out its Q3 results for all us nose-to-the-grindstone...

Ellington's Q3 Earnings Call: What Investors Need to Know

An Anticipated Unveiling Ellington Financial Inc. (NYSE:EFC) is gearing up to spill the beans on its third-quarter financials for 2026. It's all going down after the markets close on November 4th. I can tell you, folks, anyone keeping an eye on EFC will be itching to know what's inside those numbers. With a company this deep into financial assets, reading between the...

Podium Surges Past $150M in AI ARR Milestone

A New Era for Podium When the brass at Podium made a gamble on AI, they didn't just try squeezing it into their old business model. Oh no, they launched what feels like a startup within their existing empire—no half-measures, just full-throttle ambition. Fast forward two and a half years, and they've racked up over $150 million in annual recurring revenue from these...

Harbour BioMed's Batoclimab Injected Into Myasthenia Market

China's Green Light for Batoclimab When a new drug approval hits, particularly in a crucial market like China, it's a big deal. Harbour BioMed's recent go-ahead from the National Medical Products Administration (NMPA) for their Batoclimab injection is no exception. This marks the first full clinical cycle completion of an anti-FcRn treatment for generalized myasthenia...

Gillis Joins McGinnis Lochridge as COO Amid Firm's Milestone

An Experienced Executor at the Helm Now, here's a story that rings of continuity meeting change. McGinnis Lochridge, a staple of the Texas legal scene since 1927, has tapped Charles Gillis to take charge as their Chief Operating Officer. You'd think they're gearing up to celebrate a hundred years by shaking things up internally. Why not bring in someone seasoned, I say?...

Dott's Q3 2026: Micromobility Growth Soars High

Riding the Wave of Profit in Micromobility Sometimes all you need is a quick jolt of genius to turn the wheels of fortune. Dott seems to have hit that sweet spot in Q3 of 2026. Deploying 45,000 new vehicles wasn’t just a logistical feat; it was a calculated bet that paid off handsomely, bolstering their business to soaring heights. Performance that Packs a Punch The Q3...

NYC's Carriage Horse Ban: A New Era for Urban Welfare

You've got to hand it to New York City—this isn't just another Tuesday twist. The City Council's decision to nix horse-drawn carriages is like throwing a wrench in an antique machine. It's a bold move in a concrete jungle that's constantly wearing new coats. Tradition vs. Welfare: The Crux For years, the idea of horses prancing down NYC streets seemed like a quaint nod...